Wayne H Winegarden
Business & Economics
Penalizing Mergers And Acquisitions Won’t Accelerate Economic Growth
The U.S. is mired in a growth slowdown… The growth slowdown is not preordained; it is a policy driven outcome that can be reversed by implementing the right reforms. Toward this goal, a ruling by the U.S. Tax Court this past summer made small but significant progress. Read the op-ed ...
Commentary
Business Policy CMS Shouldn’t Expand Its Broken Competitive Bidding Model
Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment model has long eluded the Centers for Medicare and Medicaid Services (CMS). Disconcertingly, they now plan to expand a ...
Commentary
California’s lawsuit against energy companies will increase greenhouse gas emissions
This fall the San Francisco Superior Court is holding a hearing on California’s lawsuit against American energy companies. The lawsuit alleges that these private U.S. companies misled the public about greenhouse gases’ impact and are responsible for covering the costs associated with climate disasters. But California and the federal government ...
Commentary
It’s Time To Let The Electric Vehicle Industry Grow Up
The U.S. has been subsidizing electric vehicles (EVs) since 2009 and hybrid vehicles for even longer. Recent Congressional actions have substantially changed this policy. As part of the reconciliation package, Congress rolled back the $7,500 federal EV tax credit ($4,000 credit for used EVs) as well as the EV battery ...
Business & Economics
Using The Government To Crush Competitors Harms Fans And The Economy
Cronyism and industrial policy are thriving to the detriment of our economic vibrancy. Consider that between 1960 and 2007 – right before the Great Recession – the economy expanded by more than 3% annually. Recessions happened, of course, but the economy always recovered the lost ground. Read the op-ed here.
Commentary
The Inflationary Effect of Drug Price Controls
In a bill chock full of bad policies, the drug pricing provision of the Inflation Reduction Act stands out as particularly troubling. This provision establishes a negotiation process to set a Maximum Fair Price (MFP) on selected drugs for Medicare patients. Because the legislation calls the MFP a negotiation doesn’t ...
Blog
California’s Counterproductive Approach to Reducing GHG Emissions
California’s Counterproductive Approach to Reducing GHG Emissions by Wayne Winegarden | August 19, 2025 The state of California, along with a host of other cities and municipalities, is suing American energy companies. The lawsuit alleges that these private U.S. companies misled the public about greenhouse gases’ impact on the climate ...
Blog
Pulling mRNA Research Funding Undermines Future Innovations
Pulling mRNA Research Funding Undermines Future Innovations by Wayne Winegarden | August 15, 2025 The U.S. is a global leader in the innovative pharmaceutical industry, in part, because the public and private sectors effectively fulfill their complimentary roles. The federal government funds basic research that expands our knowledge base; the ...
Health Care
New PRI Study: Reforms to Expand PACE Program Could Save Taxpayers Billions, Improve Senior Care
SACRAMENTO – A new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute calls for reforms to expand the reach of the Program of All-Inclusive Care for the Elderly (PACE), a joint Medicare and Medicaid program that delivers comprehensive medical and social ...
Commentary
Greater Price Transparency Will Improve Affordability
Inefficiencies plague our current healthcare system. Politicians are quick to blame these problems on the market and subsequently advocate for ever greater government control. But government programs, which are already major players in the healthcare market, provide lousy insurance for patients and undermine the viability of doctors and hospitals. Expanding ...
Penalizing Mergers And Acquisitions Won’t Accelerate Economic Growth
The U.S. is mired in a growth slowdown… The growth slowdown is not preordained; it is a policy driven outcome that can be reversed by implementing the right reforms. Toward this goal, a ruling by the U.S. Tax Court this past summer made small but significant progress. Read the op-ed ...
Business Policy CMS Shouldn’t Expand Its Broken Competitive Bidding Model
Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment model has long eluded the Centers for Medicare and Medicaid Services (CMS). Disconcertingly, they now plan to expand a ...
California’s lawsuit against energy companies will increase greenhouse gas emissions
This fall the San Francisco Superior Court is holding a hearing on California’s lawsuit against American energy companies. The lawsuit alleges that these private U.S. companies misled the public about greenhouse gases’ impact and are responsible for covering the costs associated with climate disasters. But California and the federal government ...
It’s Time To Let The Electric Vehicle Industry Grow Up
The U.S. has been subsidizing electric vehicles (EVs) since 2009 and hybrid vehicles for even longer. Recent Congressional actions have substantially changed this policy. As part of the reconciliation package, Congress rolled back the $7,500 federal EV tax credit ($4,000 credit for used EVs) as well as the EV battery ...
Using The Government To Crush Competitors Harms Fans And The Economy
Cronyism and industrial policy are thriving to the detriment of our economic vibrancy. Consider that between 1960 and 2007 – right before the Great Recession – the economy expanded by more than 3% annually. Recessions happened, of course, but the economy always recovered the lost ground. Read the op-ed here.
The Inflationary Effect of Drug Price Controls
In a bill chock full of bad policies, the drug pricing provision of the Inflation Reduction Act stands out as particularly troubling. This provision establishes a negotiation process to set a Maximum Fair Price (MFP) on selected drugs for Medicare patients. Because the legislation calls the MFP a negotiation doesn’t ...
California’s Counterproductive Approach to Reducing GHG Emissions
California’s Counterproductive Approach to Reducing GHG Emissions by Wayne Winegarden | August 19, 2025 The state of California, along with a host of other cities and municipalities, is suing American energy companies. The lawsuit alleges that these private U.S. companies misled the public about greenhouse gases’ impact on the climate ...
Pulling mRNA Research Funding Undermines Future Innovations
Pulling mRNA Research Funding Undermines Future Innovations by Wayne Winegarden | August 15, 2025 The U.S. is a global leader in the innovative pharmaceutical industry, in part, because the public and private sectors effectively fulfill their complimentary roles. The federal government funds basic research that expands our knowledge base; the ...
New PRI Study: Reforms to Expand PACE Program Could Save Taxpayers Billions, Improve Senior Care
SACRAMENTO – A new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute calls for reforms to expand the reach of the Program of All-Inclusive Care for the Elderly (PACE), a joint Medicare and Medicaid program that delivers comprehensive medical and social ...
Greater Price Transparency Will Improve Affordability
Inefficiencies plague our current healthcare system. Politicians are quick to blame these problems on the market and subsequently advocate for ever greater government control. But government programs, which are already major players in the healthcare market, provide lousy insurance for patients and undermine the viability of doctors and hospitals. Expanding ...
